Type 2 diabetes in adults with sickle cell disease: can we dive deeper? Response to Skinner et al.
Type 2 diabetes in adults with sickle cell disease: can we dive deeper? Response to Skinner et al.
复制标题
镰状细胞病成人 2 型糖尿病:我们可以更深入地研究吗?
DOI:
10.1111/bjh.15949
复制
发表时间:
2019
影响因子:
6.5
通讯作者:
Calip,GregoryS
中科院分区:
文献类型:
--
作者:
Zhou,Jifang;Han,Jin;Nutescu,EdithA;Galanter,WilliamL;Walton,SurreyM;Gordeuk,VictorR;Saraf,SantoshL;Calip,GregoryS
We read with interest the letter from Skinner, Nader and Connes and their comments on our recently published study on the burden of type 2 diabetes (T2D) in patients with sickle cell disease (SCD)(Skinner, et al 2019, Zhou, et al 2019). The authors call attention to variation in T2D risk across patients with different SCD genotypes. Despite the fact that SCD is caused by single gene disorders, patients with SCD demonstrate a complex spectrum of complications and phenotypic heterogeneity that can be partially explained by the variability of fetal hemoglobin levels and co-inheritance of alpha thalassemia. It is plausible to speculate that SCD patients of different genetic foundation could present distinct pathophysiology features including lipid profile and anthropometrics, which in turn could influence the likelihood of being diagnosed with T2D.To answer the questions raised by Dr. Skinner and colleagues, we must acknowledge the inherent limitations of administrative health databases in performing studies of disease burden. Herein we describe the challenges of further exploration of these currently available data and the necessary methodological considerations for such epidemiological studies, particularly possible information and selection biases.